Clinical Research Monitoring Visits and Common Issues Explained

All CRA’s know that whenever a new amendment for a protocol is approved, each site must re re-consent their subjects. Failure to do so will result in a deviation. As mentioned in this video, CRA’s should ask the site to prepare a CAPA (Corrective Action Preventive Action) for major deviations such as failure to consent a study participant.